Clinical Trial Update: Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating switching from enfuvirtide to raltegravir in HIV patients with undetectable viral load, focusing on efficacy and tolerability of the sw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fuzeon (enfuvirtide)
• Isentress (Raltegravir)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections | Phase 3 | Status: COMPLETED